Back to Trials
NCT00527839Recruiting

Hospital for Special Surgery Shoulder Arthroplasty Cohort

Hospital for Special Surgery, New York

Start Date

4/1/2007

Completion Date

4/1/2027

Summary

Total joint replacements are some of the most successful medical devices developed over the last fifty years. They enable millions of people to remain ambulatory and pain free, with minimal risk. In 2002, over 200,000 total hip replacements, 350,000 total knee replacements, and 25,000 total or partial shoulder replacements were performed in the United States (HCUP data). Future use will likely be even higher: it is estimated that by the year 2020, the population 65 and over in developed countries will increase by 71%. Existing studies do not provide adequate prospective data to evaluate long-term outcomes. HSS is a world leader in total joint replacement including total shoulder arthroplasty. However, there is no systematic follow-up or evaluation of patients who have their shoulders replaced here. The purpose of this study is to establish a prospective cohort of HSS total shoulder arthroplasty to evaluate predictors of outcome, causes of failure and to allow ongoing evaluation of the results of our patients over time.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * 18 years or older and undergoing total shoulder arthroplasty at HSS Exclusion Criteria: * No other exclusion criteria. Pregnant women are eligible for the registry as this is a non-interventional study which only involves filling out questionnaires.

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Shoulder Arthroplasty

Locations

Hospital for Special Surgery

New York, New York 10021

United States

Hospital for Special Surgery

New York, New York 10021

United States